CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis

Area of Science:

• Immunogenetics
• Neuroimmunology
• Human Genetics

Background:

• Multiple Sclerosis (MS) is a complex neurological disorder with a suspected genetic component.
• The cytotoxic T-lymphocyte-associated protein 4 (CTLA4) gene is a potential candidate for MS susceptibility.
• Genetic variations in CTLA4 may influence immune responses relevant to MS pathogenesis.

Purpose of the Study:

• To investigate the association between CTLA4 gene polymorphisms and Multiple Sclerosis (MS) in a Norwegian population.
• To analyze the distribution of specific CTLA4 gene dimorphisms (exon 1 +49 A/G and promoter -318 C/T) in MS patients and healthy controls.

Main Methods:

• Genotyping of CTLA4 gene variations using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP).
• Analysis of allele and genotype frequencies in 296 Norwegian MS patients and 271 matched controls.
• Statistical comparison of genotype distributions between patient and control groups, including subgroup analyses.

Main Results:

• The exon 1 (+49) A-G genotype of the CTLA4 gene was significantly more frequent in MS patients (57%) compared to controls (44%) (Pcorrected=0.01).
• This increased frequency was even more pronounced in patients with relapsing-remitting MS (59%) (Pcorrected=0.006).
• No significant associations were found for other CTLA4 polymorphisms or in relation to HLA-DRB1*1501/DQB1*0602 status.

Conclusions:

• The CTLA4 gene, particularly the exon 1 (+49) A-G polymorphism, may represent a susceptibility factor for Multiple Sclerosis in the Norwegian population.
• These findings contribute to understanding the genetic underpinnings of MS.
• Further research is warranted to elucidate the functional mechanisms linking CTLA4 variants to MS risk.